155 related articles for article (PubMed ID: 3136114)
1. Sandwich radioimmunometric assay with murine monoclonal antibody, NCC-ST-439, for serological diagnosis of human cancers.
Sugano K; Ohkura H; Maruyama T; Watanabe M; Hirohashi S; Shimosato Y; Kodaira S; Abe O
Jpn J Cancer Res; 1988 May; 79(5):618-25. PubMed ID: 3136114
[TBL] [Abstract][Full Text] [Related]
2. Selection of a monoclonal antibody reactive with a high-molecular-weight glycoprotein circulating in the body fluid of gastrointestinal cancer patients.
Sakurai Y; Hirohashi S; Shimosato Y; Kodaira S; Abe O
Cancer Res; 1988 Jul; 48(14):4053-8. PubMed ID: 2454734
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 72) on a novel pancarcinoma antigen (TAG-72).
Klug TL; Sattler MA; Colcher D; Schlom J
Int J Cancer; 1986 Nov; 38(5):661-9. PubMed ID: 2429934
[TBL] [Abstract][Full Text] [Related]
4. Measurement of a monoclonal-antibody-defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen.
Gupta MK; Arciaga R; Bocci L; Tubbs R; Bukowski R; Deodhar SD
Cancer; 1985 Jul; 56(2):277-83. PubMed ID: 2408729
[TBL] [Abstract][Full Text] [Related]
5. Production of monoclonal antibodies to serum antigens in colorectal carcinoma.
Teh JG; Thompson CH; McKenzie IF
J Immunol Methods; 1988 May; 110(1):101-9. PubMed ID: 3286775
[TBL] [Abstract][Full Text] [Related]
6. Detection of a circulating gastrointestinal cancer antigen in sera of patients with gastrointestinal malignancies by a double determinant immunoassay with monoclonal antibodies against human blood group determinants.
Herlyn M; Shen JW; Sears HF; Civin CI; Verrill HL; Goldberg EM; Koprowski H
Clin Exp Immunol; 1984 Jan; 55(1):23-35. PubMed ID: 6198117
[TBL] [Abstract][Full Text] [Related]
7. Carcinoembryonic antigen, CA 19-9, and CA 125 in normal and carcinomatous human colorectal tissue.
Quentmeier A; Möller P; Schwarz V; Abel U; Schlag P
Cancer; 1987 Nov; 60(9):2261-6. PubMed ID: 3481558
[TBL] [Abstract][Full Text] [Related]
8. The value of CA 19-9 in gastric and colorectal carcinoma.
Safi F; Bittner R; Roscher R; Kübel R; Beger HG
Cancer Invest; 1987; 5(5):401-7. PubMed ID: 3480768
[TBL] [Abstract][Full Text] [Related]
9. Measurement of a pancreatic cancer-associated antigen (DU-PAN-2) detected by a monoclonal antibody in sera of patients with digestive cancers.
Sawabu N; Toya D; Takemori Y; Hattori N; Fukui M
Int J Cancer; 1986 May; 37(5):693-6. PubMed ID: 3457770
[TBL] [Abstract][Full Text] [Related]
10. [Clinical study of the NCC-ST-439 EIA kit using serum from patients with various types of cancer and benign disease (2)].
Ohkura H; Hattori N; Miyazaki I; Sawabu N; Tobe R; Kawai K; Abe O; Ishii M; Kawai T; Kamano T
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1907-12. PubMed ID: 2439021
[TBL] [Abstract][Full Text] [Related]
11. [Preoperative determination of carcinoembryonic antigen and gastrointestinal antigen in neoplastic colorectal pathology. Case contributions].
Ramella A; Bussone R; Sanlorenzo M; Natta F; Caldarola B; Schirripa C; Giani R; Pecchio F; Rocca N
Minerva Chir; 1987 Jun; 42(12):1037-43. PubMed ID: 3476864
[No Abstract] [Full Text] [Related]
12. [CA 19-9 in early cancers of the bronchi. Comparison with the carcinoembryogenic antigen].
Vindimian M; Lafitte JJ; Wattre P
Biomed Pharmacother; 1987; 41(4):191-5. PubMed ID: 3476162
[TBL] [Abstract][Full Text] [Related]
13. Use of four monoclonal antibodies to detect tumor markers.
Kawahara M; Terasaki PI; Chia D; Johnson C; Hermes M; Tokita K
Cancer; 1986 Nov; 58(9):2008-12. PubMed ID: 2428463
[TBL] [Abstract][Full Text] [Related]
14. [A radioimmunometric assay for circulating tumor-associated glycoprotein (TAG-72) using the antigen determinant CA 72-4].
Ohuchi N; Takahashi K; Matoba N; Mori S
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2761-6. PubMed ID: 2458074
[TBL] [Abstract][Full Text] [Related]
15. The significance of CA19-9 tumor antigen in the serum of patients with carcinomas.
Wang FM; Tsai LC; Chang ZN; Han SH; Tsao D
Proc Natl Sci Counc Repub China B; 1985 Apr; 9(2):119-25. PubMed ID: 3863154
[TBL] [Abstract][Full Text] [Related]
16. Detection of monoclonal antibody-defined colorectal carcinoma antigen by solid-phase binding inhibition radioimmunoassay.
Chang TH; Steplewski Z; Sears HF; Koprowski H
Hybridoma; 1981; 1(1):37-45. PubMed ID: 6926850
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of tumor marker NCC-ST 439 in large bowel cancers.
Yamaguchi A; Kurosaka Y; Ishida T; Nishimura G; Kanno M; Kosaka T; Yonemura Y; Miyazaki I
Dis Colon Rectum; 1991 Oct; 34(10):921-4. PubMed ID: 1914727
[TBL] [Abstract][Full Text] [Related]
18. A radioimmunoassay for the detection of a human tumor-associated glycoprotein (TAG-72) using monoclonal antibody B72.3.
Paterson AJ; Schlom J; Sears HF; Bennett J; Colcher D
Int J Cancer; 1986 May; 37(5):659-66. PubMed ID: 3699929
[TBL] [Abstract][Full Text] [Related]
19. Detection of sialylated LewisX antigen in cancer sera using a sandwich radioimmunoassay.
Kawahara M; Chia D; Terasaki PI; Roumanas A; Sugich L; Hermes M; Iguro T
Int J Cancer; 1985 Oct; 36(4):421-5. PubMed ID: 2995258
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of the tumor markers CEA and CA 19-9 in colorectal diagnosis].
Heptner G; Domschke S; Krapf F; Schneider MU; Iro H; Domschke W
Dtsch Med Wochenschr; 1984 Aug; 109(35):1309-12. PubMed ID: 6590287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]